Barclays Lowers Informa (INF) Price Target to GBX 855

Informa (LON:INF) had its target price reduced by analysts at Barclays from GBX 885 ($11.56) to GBX 855 ($11.17) in a report issued on Monday, November 12th. The brokerage presently has an “overweight” rating on the stock. Barclays’ target price would suggest a potential upside of 31.18% from the company’s previous close.

Several other brokerages also recently issued reports on INF. UBS Group reissued a “buy” rating on shares of Informa in a research note on Tuesday, July 24th. Shore Capital reaffirmed a “buy” rating on shares of Informa in a research note on Friday, July 20th. Liberum Capital reaffirmed a “buy” rating on shares of Informa in a research note on Wednesday, July 25th. Citigroup lifted their price target on shares of Informa from GBX 750 ($9.80) to GBX 880 ($11.50) and gave the company a “neutral” rating in a research note on Monday, July 23rd. Finally, Peel Hunt reaffirmed a “hold” rating on shares of Informa in a research note on Wednesday, July 25th. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of GBX 870.67 ($11.38).

LON INF traded down GBX 11 ($0.14) during trading on Monday, hitting GBX 651.80 ($8.52). The stock had a trading volume of 4,075,730 shares, compared to its average volume of 3,640,000. Informa has a one year low of GBX 624.50 ($8.16) and a one year high of GBX 773 ($10.10).

Informa Company Profile

Informa plc engages in business intelligence, academic publishing, and knowledge and events businesses worldwide. The company operates through Academic Publishing, Business Intelligence, Global Exhibitions, and Knowledge & Networking segments. The Academic Publishing segment publishes academic books and journals in print and digital formats for university libraries and departments, specialist research institutions, and individuals in the areas of humanities and social sciences, science, technology, and medicine.

Read More: How to calculate the annual rate of depreciation

Analyst Recommendations for Informa (LON:INF)

Receive News & Ratings for Informa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Informa and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply